Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Feb 09, 2026
UBS vs HSBC: Earnings Preview as Q4 Results Could Shift European Bank Sentiment

UBS vs HSBC: Earnings Preview as Q4 Results Could Shift European Bank Sentiment

Key Takeaways

  • UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY.

  • UBS has beat EPS estimates in the last four quarters by an average of 53%, driven by wealth management inflows and cost savings from Credit Suisse integration.

  • HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.

  • Both banks target mid-teens RoTE, with UBS advancing Credit Suisse integration, and HSBC focusing on Asia wealth expansion and cost discipline.

  • UBS emphasizes Swiss precision in wealth and investment banking, while HSBC leverages global scale, especially in Hong Kong and Asia.

  • Investor focus: UBS on integration milestones, HSBC on NII trajectory amid evolving interest rates.

Earnings Context and Why It Matters

UBS’s Q4 report closes a transformative year post-Credit Suisse acquisition, with investors monitoring progress on $13 billion in gross cost savings and non-core asset wind-downs. Despite a revenue dip from elevated prior-year levels, EPS growth is expected, supported by strong wealth inflows and a rebound in investment banking.

HSBC’s Q4 report highlights a different strategy: a global universal bank with a strong Asian focus. Comparing UBS and HSBC underscores diverging paths in European banking—UBS’s wealth-centric Swiss model versus HSBC’s diversified, Asia-driven approach. Both face geopolitical and interest rate pressures, but UBS’s integration execution and HSBC’s NII expansion showcase sector resilience, providing investors insight into European banking stability amid global volatility.

UBS: Earnings in Focus

  • Consensus EPS: $0.25–$0.67 (TipRanks median $0.54) vs. $0.23 last year.

  • Revenue: ~$11.62 billion, down YoY.

  • Key metrics:

    • Global Wealth Management net new assets (Q3: $38B quarterly)

    • Cumulative cost savings: $9.1B toward $13B target

    • CET1 ratio: ~14%

    • Non-Core/Legacy RWA reduction: Target < $8B by 2025-end

Investment banking revenues may benefit from solid Q4 deal flow. Historically, UBS has beat estimates by 53% on average, with stock reactions mixed (e.g., -2% post-Q3). Management guidance emphasizes completion of 2026 integration, supporting a ~15% RoCET1 target.

HSBC: Context and Earnings Relevance

  • Q4 consensus EPS: ~$1.57 vs. $1.45 prior.

  • Q3 highlights: Revenue $17.9B (+3% YoY), pre-tax profit $7.3B despite $1.4B legal provisions, NII +15% to $8.8B, and YTD RoTE 17.6% ex-notables.

  • Strategy emphasizes four core businesses (Hong Kong, UK, CIB, Wealth/Premier), mid-single-digit cost growth, and Hang Seng privatization.

  • HSBC’s emerging market exposure contrasts with UBS’s premium Swiss wealth focus. Both prioritize capital returns through dividends and buybacks.

Head-to-Head Earnings and Market Comparison

  • Scale and focus: HSBC ~$63B trailing revenue vs. UBS ~$39B, but UBS delivers higher margins in wealth management (Q3 NNA $92B YTD) vs. HSBC’s volume-driven growth.

  • Earnings quality: UBS average EPS surprise 53%, HSBC consistently strong ex-notables.

  • Growth drivers: UBS’s Credit Suisse synergies (70% of cost saves achieved); HSBC’s Asia pivot (wealth fees double-digit medium-term growth).

  • Risks: UBS faces legacy litigation and integration challenges; HSBC contends with property exposure (Hang Seng NPLs).

  • Valuation and sentiment: UBS trades at a premium, reflecting transformation progress, while HSBC remains a steady execution play amid interest rate sensitivity.

Tickeron AI Perspective

Tickeron AI Verdict

Tickeron’s AI models currently favor UBS, citing:

  • Superior earnings surprise history

  • Accelerating cost efficiencies

  • Positioned growth in high-margin wealth and investment banking

HSBC offers scale and NII resilience, but UBS’s integration execution and RoCET1 trajectory give it a probabilistic edge for outperformance, assuming no major shocks.

Disclaimers and Limitations

Related Ticker: UBS, HSBC

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


Momentum Indicator for UBS turns negative, indicating new downward trend

UBS saw its Momentum Indicator move below the 0 level on August 21, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 76 similar instances where the indicator turned negative. In of the 76 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for UBS turned negative on July 20, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 40 similar instances when the indicator turned negative. In of the 40 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where UBS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where UBS advanced for three days, in of 347 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 322 cases where UBS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 20, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. UBS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.830) is normal, around the industry mean (1.897). UBS has a moderately high P/E Ratio (18.126) as compared to the industry average of (15.307). Projected Growth (PEG Ratio) (0.869) is also within normal values, averaging (1.603). Dividend Yield (0.021) settles around the average of (0.026) among similar stocks. P/S Ratio (3.392) is also within normal values, averaging (3.937).

Notable companies

The most notable companies in this group are JPMorgan Chase & Co (NYSE:JPM), Bank of America Corp (NYSE:BAC), HSBC Holdings PLC (NYSE:HSBC), Wells Fargo & Co (NYSE:WFC), Citigroup (NYSE:C), Barclays PLC (NYSE:BCS).

Industry description

Major banks are among the biggest companies in the world, often times with global reach and market capitalizations in the multi-billions. Large banks often have multiple arms spanning different disciplines, from deposits, to investment banking, to wealth management and insurance. The biggest banks often have key competitive advantages over smaller players in the industry in terms of brand recognition, cost of capital, and efficiency. Think J.P. Morgan, Bank of America, Wells Fargo, and Citigroup.

Market Cap

The average market capitalization across the Major Banks Industry is 212.62B. The market cap for tickers in the group ranges from 1.04M to 934.57B. JPM holds the highest valuation in this group at 934.57B. The lowest valued company is BACRP at 1.04M.

High and low price notable news

The average weekly price growth across all stocks in the Major Banks Industry was -4%. For the same Industry, the average monthly price growth was -0%, and the average quarterly price growth was 17%. BBVA experienced the highest price growth at 1%, while NTB experienced the biggest fall at -8%.

Volume

The average weekly volume growth across all stocks in the Major Banks Industry was 35%. For the same stocks of the Industry, the average monthly volume growth was -21% and the average quarterly volume growth was -11%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 66
P/E Growth Rating: 32
Price Growth Rating: 43
SMR Rating: 7
Profit Risk Rating: 19
Seasonality Score: -24 (-100 ... +100)
View a ticker or compare two or three
UBS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a major bank

Industry MajorBanks

Profile
Details
Industry
Major Banks
Address
Bahnhofstrasse 45
Phone
+41 442341111
Employees
112842
Web
https://www.ubs.com
Interact to see
Advertisement
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Intercontinental Exchange (ICE) has navigated recent market volatility while remaining within its 52-week range. Broader weakness in financial data and exchange operators has created short-term pressure, but ICE’s diversified business model continues to provide stability.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.